Rhythm Pharmaceuticals (RYTM) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to -$9.4 million.
- Rhythm Pharmaceuticals' Other Gross PP&E Adjustments fell 14.98% to -$9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.4 million, marking a year-over-year decrease of 14.98%. This contributed to the annual value of -$2.4 million for FY2024, which is 40000.0% down from last year.
- Per Rhythm Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at -$9.4 million for Q3 2025, which was down 14.98% from -$8.1 million recorded in Q2 2025.
- Rhythm Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $1.4 million for Q4 2021, and its period low was -$9.4 million during Q3 2025.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$4.5 million (2023), whereas its average is -$4.9 million.
- As far as peak fluctuations go, Rhythm Pharmaceuticals' Other Gross PP&E Adjustments surged by 33674.7% in 2023, and later plummeted by 40000.0% in 2024.
- Over the past 5 years, Rhythm Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $1.4 million in 2021, then tumbled by 123.95% to -$332000.0 in 2022, then surged by 336.75% to $786000.0 in 2023, then tumbled by 400.0% to -$2.4 million in 2024, then tumbled by 297.03% to -$9.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$9.4 million for Q3 2025, versus -$8.1 million for Q2 2025 and -$8.1 million for Q1 2025.